Exact Mass: 456.2123472
Exact Mass Matches: 456.2123472
Found 500 metabolites which its exact mass value is equals to given mass value 456.2123472
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Kurarinol
Kurarinol is a trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2 and 4 , a methoxy group at position 5 and a (2S)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 8 respectively. It has a role as an anti-inflammatory agent, an antioxidant and a plant metabolite. It is a trihydroxyflavanone, a monomethoxyflavanone and a member of 4-hydroxyflavanones. It is functionally related to a (2S)-flavanone. Kurarinol is a natural product found in Albizia julibrissin and Sophora flavescens with data available. A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2 and 4 , a methoxy group at position 5 and a (2S)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 8 respectively.
Vindoline
Vindoline is a vinca alkaloid, an alkaloid ester, an organic heteropentacyclic compound, a methyl ester, an acetate ester, a tertiary amino compound and a tertiary alcohol. It is a conjugate base of a vindolinium(1+). Vindoline is a natural product found in Catharanthus ovalis, Catharanthus trichophyllus, and other organisms with data available. Vindoline is an indole alkaloid that exhibits antimitotic activity by inhibiting microtubule assembly. (NCI) D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1744 - Multidrug Resistance Modulator Vindoline, a vinca alkaloid extracted from the leaves of Catharanthus roseus, weakly inhibits tubulin self-assembly[1]. Vindoline, a vinca alkaloid extracted from the leaves of Catharanthus roseus, weakly inhibits tubulin self-assembly[1].
Delavirdine
C22H28N6O3S (456.19434980000005)
Delavirdine is only found in individuals that have used or taken this drug. It is a potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. [PubChem]Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzymes catalytic site. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
Kuraridinol
A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2, 4, 2 and 4, a methoxy group at position 6 and a 5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 3 respectively.
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Sudan black B
Vindoline
2,6-Bis(4-hydroxybenzyl)-3,3-dihydroxy-5-methoxybibenzyl
Melianthugenin
1-(3-Furyl)-5-hydroxy-4b,7,7,9b,11a-pentamethyldodecahydrooxireno[2,3-d]oxireno[2,3:7,8]naphtho[2,1-f]isochromene-3,8(3ah,4bh)-dione #
13-Me ether,3-O-beta-D-glucopyranoside-3,8,13-Trihydroxy-4(15),10(14)-guaiadien-12,6-olide
berkeleydione
A meroterpenoid found in Penicillium rubrum. It has been shown to exhibit inhibitory activity against caspase-1.
4-[2-(3-Methoxyphenyl)ethyl]-2-[4-[2-(2,5-dihydroxyphenyl)ethyl]phenoxy]phenol
1,5,8-Trihydroxy-12,13-dihydro-3,10-dimethyl-5,12-diisopropyldibenzo[a,h]anthracene-6(5H)-one
(8E)-decaene-4,6-diyn-1-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
2,2-Dimethyl-5,10-dimethoxy-9-hydroxy-11-(3-methoxy-3-methylbutyl)-2,3,4,12-tetrahydro-1,7-dioxabenzo[a]anthracene-12-one
(+)-chloranthalacatone F|(1aS,5aR,5bR,9aS,10aS,11aR,11bS,11cS,11dS,11eS,11fR,12aS)-3,8,11b,11e-tetramethyl-1,10-dimethylene-1,1a,2,9,9a,10,10a,11,11a,11d,11e,11f,12,12a-tetradecahydrocyclopropa[3,4]cyclopenta[1,2:3,4]cyclopenta[1,2:5,6]biphenyleno[8a,8-b:8b,1-b]difuran-4,7(11bH,11cH)-dione|chloranthalactone A photodimer|Chloranthalactone F
1-(2-hydroxy-3-O-beta-D-cymaropyranosyl-6-O-beta-D-oleandropyranosyl-phenyl)-ethanone
(2S)-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin B
jatairidoids C|[(1R,3R,4aR,6S,7R,7aS)-6-(acetyloxy)hexahydro-1,4a-dihydroxy-4-methylidene-3,7-epoxycyclopenta[c]pyran-7(1H)-yl]methyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate
8,10-dihydroxy-5a-isopropyl-2,2,4,4-tetramethyl-7-(3-methylbutyryl)-5a,10b-dihydro-4H-benzo[b]benzo[4,5]furo[3,2-d]furan-1,3-dione|rhodomyrtosone A
(2S)-8-(5-hydroxy-2-isoprenyl-5-methylhexyl)-7-methoxy-5,2,4-trihydroxyflavanone
16-methoxy-cathovaline|Dihydrovindoline ether|Dihydrovindolinether|ent-4alpha-acetoxy-3,6alpha-epoxy-16-methoxy-1-methyl-aspidospermidine-3beta-carboxylic acid methyl ester
(2S)-6-[2-(1-hydroxy-1-methylethyl)-5-methyl-4-hexenyl]-5-methoxy-7,2,4-trihydroxyflavanone
1,6-Dihydroxy-2-(3-methyl-2-butenyl)-3,7-dimethoxy-8-(3-methoxy-3-methylbutyl)-9H-xanthene-9-one
16beta-acetoxy-3beta,14beta-dihydroxy-19-oxo-bufa-4,20,22-trienolide|scillicyanosidin
1,7-Dideacetoxy-1,7-Dioxo-3-Deacetylkhivorin_major
Ala Glu His Thr
Ala Glu Thr His
Ala Phe Gly Tyr
Ala Phe Tyr Gly
Ala Gly Phe Tyr
Ala Gly Tyr Phe
Ala His Glu Thr
Ala His Met Val
Ala His Thr Glu
Ala His Val Met
Ala Met His Val
Ala Met Val His
Ala Thr Glu His
Ala Thr His Glu
Ala Val His Met
Ala Val Met His
Ala Tyr Phe Gly
Ala Tyr Gly Phe
Cys His Val Val
Cys Val His Val
Cys Val Val His
Asp His Ser Val
Asp His Val Ser
Asp Ser His Val
Asp Ser Val His
Asp Val His Ser
Asp Val Ser His
Glu Ala His Thr
Glu Ala Thr His
Glu His Ala Thr
Glu His Thr Ala
Glu Thr Ala His
Glu Thr His Ala
Phe Ala Gly Tyr
Phe Ala Tyr Gly
Phe Phe Gly Ser
Phe Phe Ser Gly
Phe Gly Ala Tyr
Phe Gly Phe Ser
Phe Gly His Pro
Phe Gly Pro His
Phe Gly Ser Phe
Phe Gly Tyr Ala
Phe His Gly Pro
Phe His Pro Gly
Phe Pro Gly His
Phe Pro His Gly
Phe Ser Phe Gly
Phe Ser Gly Phe
Phe Tyr Ala Gly
Phe Tyr Gly Ala
Gly Ala Phe Tyr
Gly Ala Tyr Phe
Gly Phe Ala Tyr
Gly Phe Phe Ser
Gly Phe His Pro
Gly Phe Pro His
Gly Phe Ser Phe
Gly Phe Tyr Ala
Gly His Phe Pro
Gly His Ile Met
Gly His Leu Met
Gly His Met Ile
Gly His Met Leu
Gly His Pro Phe
Gly Ile His Met
Gly Ile Met His
Gly Leu His Met
Gly Leu Met His
Gly Met His Ile
Gly Met His Leu
Gly Met Ile His
Gly Met Leu His
Gly Pro Phe His
Gly Pro His Phe
Gly Ser Phe Phe
Gly Tyr Ala Phe
Gly Tyr Phe Ala
His Ala Glu Thr
His Ala Met Val
His Ala Thr Glu
His Ala Val Met
His Cys Val Val
His Asp Ser Val
His Asp Val Ser
His Glu Ala Thr
His Glu Thr Ala
His Phe Gly Pro
His Phe Pro Gly
His Gly Phe Pro
His Gly Ile Met
His Gly Leu Met
His Gly Met Ile
His Gly Met Leu
His Gly Pro Phe
His Ile Gly Met
His Ile Met Gly
His Ile Ser Thr
C19H32N6O7 (456.23323619999996)
His Ile Thr Ser
C19H32N6O7 (456.23323619999996)
His Leu Gly Met
His Leu Met Gly
His Leu Ser Thr
C19H32N6O7 (456.23323619999996)
His Leu Thr Ser
C19H32N6O7 (456.23323619999996)
His Met Ala Val
His Met Gly Ile
His Met Gly Leu
His Met Ile Gly
His Met Leu Gly
His Met Val Ala
His Pro Phe Gly
His Pro Gly Phe
His Ser Asp Val
His Ser Ile Thr
C19H32N6O7 (456.23323619999996)
His Ser Leu Thr
C19H32N6O7 (456.23323619999996)
His Ser Thr Ile
C19H32N6O7 (456.23323619999996)
His Ser Thr Leu
C19H32N6O7 (456.23323619999996)
His Ser Val Asp
His Thr Ala Glu
His Thr Glu Ala
His Thr Ile Ser
C19H32N6O7 (456.23323619999996)
His Thr Leu Ser
C19H32N6O7 (456.23323619999996)
His Thr Ser Ile
C19H32N6O7 (456.23323619999996)
His Thr Ser Leu
C19H32N6O7 (456.23323619999996)
His Thr Thr Val
C19H32N6O7 (456.23323619999996)
His Thr Val Thr
C19H32N6O7 (456.23323619999996)
His Val Ala Met
His Val Cys Val
His Val Asp Ser
His Val Met Ala
His Val Ser Asp
His Val Thr Thr
C19H32N6O7 (456.23323619999996)
His Val Val Cys
Ile Gly His Met
Ile Gly Met His
Ile His Gly Met
Ile His Met Gly
Ile His Ser Thr
C19H32N6O7 (456.23323619999996)
Ile His Thr Ser
C19H32N6O7 (456.23323619999996)
Ile Met Gly His
Ile Met His Gly
Ile Asn Asn Pro
C19H32N6O7 (456.23323619999996)
Ile Asn Pro Asn
C19H32N6O7 (456.23323619999996)
Ile Pro Asn Asn
C19H32N6O7 (456.23323619999996)
Ile Ser His Thr
C19H32N6O7 (456.23323619999996)
Ile Ser Thr His
C19H32N6O7 (456.23323619999996)
Ile Thr His Ser
C19H32N6O7 (456.23323619999996)
Ile Thr Ser His
C19H32N6O7 (456.23323619999996)
Leu Gly His Met
Leu Gly Met His
Leu His Gly Met
Leu His Met Gly
Leu His Ser Thr
C19H32N6O7 (456.23323619999996)
Leu His Thr Ser
C19H32N6O7 (456.23323619999996)
Leu Met Gly His
Leu Met His Gly
Leu Asn Asn Pro
C19H32N6O7 (456.23323619999996)
Leu Asn Pro Asn
C19H32N6O7 (456.23323619999996)
Leu Pro Asn Asn
C19H32N6O7 (456.23323619999996)
Leu Ser His Thr
C19H32N6O7 (456.23323619999996)
Leu Ser Thr His
C19H32N6O7 (456.23323619999996)
Leu Thr His Ser
C19H32N6O7 (456.23323619999996)
Leu Thr Ser His
C19H32N6O7 (456.23323619999996)
Met Ala His Val
Met Ala Val His
Met Gly His Ile
Met Gly His Leu
Met Gly Ile His
Met Gly Leu His
Met His Ala Val
Met His Gly Ile
Met His Gly Leu
Met His Ile Gly
Met His Leu Gly
Met His Val Ala
Met Ile Gly His
Met Ile His Gly
Met Leu Gly His
Met Leu His Gly
Met Val Ala His
Met Val His Ala
Asn Ile Asn Pro
C19H32N6O7 (456.23323619999996)
Asn Ile Pro Asn
C19H32N6O7 (456.23323619999996)
Asn Leu Asn Pro
C19H32N6O7 (456.23323619999996)
Asn Leu Pro Asn
C19H32N6O7 (456.23323619999996)
Asn Asn Ile Pro
C19H32N6O7 (456.23323619999996)
Asn Asn Leu Pro
C19H32N6O7 (456.23323619999996)
Asn Asn Pro Ile
C19H32N6O7 (456.23323619999996)
Asn Asn Pro Leu
C19H32N6O7 (456.23323619999996)
Asn Pro Ile Asn
C19H32N6O7 (456.23323619999996)
Asn Pro Leu Asn
C19H32N6O7 (456.23323619999996)
Asn Pro Asn Ile
C19H32N6O7 (456.23323619999996)
Asn Pro Asn Leu
C19H32N6O7 (456.23323619999996)
Asn Pro Gln Val
C19H32N6O7 (456.23323619999996)
Asn Pro Val Gln
C19H32N6O7 (456.23323619999996)
Asn Gln Pro Val
C19H32N6O7 (456.23323619999996)
Asn Gln Val Pro
C19H32N6O7 (456.23323619999996)
Asn Val Pro Gln
C19H32N6O7 (456.23323619999996)
Asn Val Gln Pro
C19H32N6O7 (456.23323619999996)
Pro Phe Gly His
Pro Phe His Gly
Pro Gly Phe His
Pro Gly His Phe
Pro His Phe Gly
Pro His Gly Phe
Pro Ile Asn Asn
C19H32N6O7 (456.23323619999996)
Pro Leu Asn Asn
C19H32N6O7 (456.23323619999996)
Pro Asn Ile Asn
C19H32N6O7 (456.23323619999996)
Pro Asn Leu Asn
C19H32N6O7 (456.23323619999996)
Pro Asn Asn Ile
C19H32N6O7 (456.23323619999996)
Pro Asn Asn Leu
C19H32N6O7 (456.23323619999996)
Pro Asn Gln Val
C19H32N6O7 (456.23323619999996)
Pro Asn Val Gln
C19H32N6O7 (456.23323619999996)
Pro Gln Asn Val
C19H32N6O7 (456.23323619999996)
Pro Gln Val Asn
C19H32N6O7 (456.23323619999996)
Pro Val Asn Gln
C19H32N6O7 (456.23323619999996)
Pro Val Gln Asn
C19H32N6O7 (456.23323619999996)
Gln Asn Pro Val
C19H32N6O7 (456.23323619999996)
Gln Asn Val Pro
C19H32N6O7 (456.23323619999996)
Gln Pro Asn Val
C19H32N6O7 (456.23323619999996)
Gln Pro Val Asn
C19H32N6O7 (456.23323619999996)
Gln Val Asn Pro
C19H32N6O7 (456.23323619999996)
Gln Val Pro Asn
C19H32N6O7 (456.23323619999996)
Ser Asp His Val
Ser Asp Val His
Ser Phe Phe Gly
Ser Phe Gly Phe
Ser Gly Phe Phe
Ser His Asp Val
Ser His Ile Thr
C19H32N6O7 (456.23323619999996)
Ser His Leu Thr
C19H32N6O7 (456.23323619999996)
Ser His Thr Ile
C19H32N6O7 (456.23323619999996)
Ser His Thr Leu
C19H32N6O7 (456.23323619999996)
Ser His Val Asp
Ser Ile His Thr
C19H32N6O7 (456.23323619999996)
Ser Ile Thr His
C19H32N6O7 (456.23323619999996)
Ser Leu His Thr
C19H32N6O7 (456.23323619999996)
Ser Leu Thr His
C19H32N6O7 (456.23323619999996)
Ser Thr His Ile
C19H32N6O7 (456.23323619999996)
Ser Thr His Leu
C19H32N6O7 (456.23323619999996)
Ser Thr Ile His
C19H32N6O7 (456.23323619999996)
Ser Thr Leu His
C19H32N6O7 (456.23323619999996)
Ser Val Asp His
Ser Val His Asp
Thr Ala Glu His
Thr Ala His Glu
Thr Glu Ala His
Thr Glu His Ala
Thr His Ala Glu
Thr His Glu Ala
Thr His Ile Ser
C19H32N6O7 (456.23323619999996)
Thr His Leu Ser
C19H32N6O7 (456.23323619999996)
Thr His Ser Ile
C19H32N6O7 (456.23323619999996)
Thr His Ser Leu
C19H32N6O7 (456.23323619999996)
Thr His Thr Val
C19H32N6O7 (456.23323619999996)
Thr His Val Thr
C19H32N6O7 (456.23323619999996)
Thr Ile His Ser
C19H32N6O7 (456.23323619999996)
Thr Ile Ser His
C19H32N6O7 (456.23323619999996)
Thr Leu His Ser
C19H32N6O7 (456.23323619999996)
Thr Leu Ser His
C19H32N6O7 (456.23323619999996)
Thr Ser His Ile
C19H32N6O7 (456.23323619999996)
Thr Ser His Leu
C19H32N6O7 (456.23323619999996)
Thr Ser Ile His
C19H32N6O7 (456.23323619999996)
Thr Ser Leu His
C19H32N6O7 (456.23323619999996)
Thr Thr His Val
C19H32N6O7 (456.23323619999996)
Thr Thr Val His
C19H32N6O7 (456.23323619999996)
Thr Val His Thr
C19H32N6O7 (456.23323619999996)
Thr Val Thr His
C19H32N6O7 (456.23323619999996)
Val Ala His Met
Val Ala Met His
Val Cys His Val
Val Cys Val His
Val Asp His Ser
Val Asp Ser His
Val His Ala Met
Val His Cys Val
Val His Asp Ser
Val His Met Ala
Val His Ser Asp
Val His Thr Thr
C19H32N6O7 (456.23323619999996)
Val His Val Cys
Val Met Ala His
Val Met His Ala
Val Asn Pro Gln
C19H32N6O7 (456.23323619999996)
Val Asn Gln Pro
C19H32N6O7 (456.23323619999996)
Val Pro Asn Gln
C19H32N6O7 (456.23323619999996)
Val Pro Gln Asn
C19H32N6O7 (456.23323619999996)
Val Gln Asn Pro
C19H32N6O7 (456.23323619999996)
Val Gln Pro Asn
C19H32N6O7 (456.23323619999996)
Val Ser Asp His
Val Ser His Asp
Val Thr His Thr
C19H32N6O7 (456.23323619999996)
Val Thr Thr His
C19H32N6O7 (456.23323619999996)
Val Val Cys His
Val Val His Cys
Tyr Ala Phe Gly
Tyr Ala Gly Phe
Tyr Phe Ala Gly
Tyr Phe Gly Ala
Tyr Gly Ala Phe
Tyr Gly Phe Ala
17-trifluoromethylphenyl trinor PGF2&alpha
Levocabastine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol,dihydrochloride
C23H34Cl2N2O3 (456.19463540000004)
3,6-BIS[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-9H-XANTHEN-9-ONE
10-([1,1-Biphenyl]-4-yl)anthracen-9-yl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C32H29BO2 (456.22604839999997)
3-Quinolineacetic acid, 4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-α-(1,1-dimethylethoxy)-2-methyl-, methyl ester, (αS,4R)-
C28H28N2O4 (456.20489680000003)
Aminophylline Dihydrate
C16H28N10O6 (456.21931880000005)
C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
7-(Furan-3-yl)-15-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecane-5,13,19-trione
1-(5Z,8Z,11Z,14Z,17Z-Eicosapentaenoyl)-glycero-3-phosphoric acid
N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-(2-furanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide
3-[(1-cyclopentyl-5-tetrazolyl)-(3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-methoxy-1H-quinolin-2-one
(2S)-2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-3-methylbutanoic acid [2-oxo-2-(4-propan-2-ylanilino)ethyl] ester
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-6-methyl-1H-quinolin-2-one
(4Z)-4-[(3-methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylidene]-2-(4-propan-2-yloxyphenyl)-1,3-oxazol-5-one
N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)butanediamide
1-[1-[[1-[(4-Methylphenyl)methyl]-5-tetrazolyl]methyl]-4-piperidinyl]-5-(trifluoromethyl)benzotriazole
N(6)-lactobionoylhexane-1,6-diamine
A primary amide formed between lactobionic acid and hexane-1,6-diamine.
Ethyl 2-[5-benzyloxy-4-(trifluoromethyl)biphenyl-3-yl]pentanoate
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(2-pyridin-4-ylethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(2-pyridin-4-ylethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
C22H36N2O6S (456.22939560000003)
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]oxane-4-carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
C22H36N2O6S (456.22939560000003)
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
C22H36N2O6S (456.22939560000003)
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyloxane-4-carboxamide
C22H36N2O6S (456.22939560000003)
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[(2R,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2S,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2S,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
C22H36N2O6S (456.22939560000003)
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
C22H36N2O6S (456.22939560000003)
[(8S,9S,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[(2S,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2S,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2R,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2R,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2R,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(4-morpholinyl)acetamide
C21H30F2N4O5 (456.21841539999997)
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
C22H36N2O6S (456.22939560000003)
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-4-oxanecarboxamide
C22H36N2O6S (456.22939560000003)
N-[(2R,4aR,12aR)-2-[2-(ethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-methyl-3-isoxazolecarboxamide
2-[(3S,6aS,8R,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
(3aR,4R,9bS)-8-(4-cyanophenyl)-N-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
C27H25FN4O2 (456.19614419999994)
[(8R,9R,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(2S,3R)-1-(4-oxanylmethyl)-3-phenyl-6-(phenylmethyl)sulfonyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
1-Arachidonoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as arachidonoyl.
2,6-dimethyl-3,4-dihydropyridine-3,4,5-tricarboxylic acid O4-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl] ester O3,O5-diethyl ester
methyl (1S,10R,11S,12S,19S)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] octanoate
C19H37O10P (456.21242320000005)
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] octanoate
C19H37O10P (456.21242320000005)
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptanoate
C19H37O10P (456.21242320000005)
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] nonanoate
C19H37O10P (456.21242320000005)
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate
C19H37O10P (456.21242320000005)
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] undecanoate
C19H37O10P (456.21242320000005)
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] heptanoate
C19H37O10P (456.21242320000005)
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] nonanoate
C19H37O10P (456.21242320000005)
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] decanoate
C19H37O10P (456.21242320000005)
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] undecanoate
C19H37O10P (456.21242320000005)
Delavirdine
C22H28N6O3S (456.19434980000005)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
2-Arachidonoyl-sn-glycero-3-phosphate(2-)
A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-arachidonoyl-sn-glycero-3-phosphate; major species at pH 7.3.
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate
phosphatidylglycerol 13:0
C19H37O10P (456.21242320000005)
A phosphatidylglycerol in which the two acyl groups contain 13 carbon atoms and no double bonds
1-Arachidonoyl-sn-glycerol 3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-arachidonoyl-sn-glycero-3-phosphate.
P2X3 antagonist 34
C24H26F2N4O3 (456.19728699999996)
P2X3 antagonist 34 is a potent, selective and orally active P2X3 homotrimeric receptor antagonist with IC50s of 25?nM, 92?nM and 126?nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively. P2X3 antagonist 34 is less active against human, rat and guinea pig P2X2/3 heterotrimeric receptors. P2X3 antagonist 34 has strong anti-tussive effect[1].